Stockreport

Could Clinical Progress With VOQUEZNA Reshape Phathom Pharmaceuticals' Long-Term Strategy (PHAT)? [Yahoo! Finance]

Phathom Pharmaceuticals, Inc.  (PHAT) 
Last phathom pharmaceuticals, inc. earnings: 3/19 08:31 am Check Earnings Report
PDF tablets for eosinophilic esophagitis (EoE) in adults, with topline results expected in 2027. This clinical milestone reflects the company's efforts to expand VOQUEZNA' [Read more]